MIRA INFORM REPORT

 

 

Report Date :

25.07.2012

 

IDENTIFICATION DETAILS

 

Name :

HIMEDIA LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

23, Vadhani Industrial Estate, L.B.S. Marg, Ghatkopar (West), Mumbai - 400 086, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

08.09.1982

 

 

Com. Reg. No.:

11-028194

 

 

Capital Investment / Paid-up Capital :

Rs. 18.225 Millions

 

 

CIN No.:

[Company Identification No.]

U85195MH1982PTC028194

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Dehydrated Culture Media, Vegetable Peptones and Microbiological Diagnostic.

 

 

No. of Employees :

Information not given by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (53)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 2000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company with good track. Financials of the company appears to be strong. Trade relations are fair. Business is active. Payments are regular and as per commitments.

 

The company can be considered good for normal business dealings under usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

EXTERNAL AGENCY RATING

 

Agency Name

Rating

CRISIL

A-      /Stable

 

 

INFORMATION DECLINED BY

           

Name :

Mr. Basant

Designation :

Accounts Manager

Contact No.:

91-22-25000970

Date :

24.07.2012

 

 

LOCATIONS

 

Registered/ Head Office :

23, Vadhani Industrial Estate, L.B.S. Marg, Ghatkopar (West), Mumbai - 400 086, Maharashtra, India

Tel. No.:

91-22-25001607/ 61169797

Fax No.:

91-22-25005764 / 25002468 / 25002286

E-Mail :

accounts@himedialabs.com

info@himedialabs.com

Website :

www.himedialabs.com

www.himedia.com

Area :

1000 sq ft

Location :

Owned

 

 

Corporate Office : 

A 516, Swastik Disha Business Park, via Vadhani Industrial Estate, L.B.S. Marg, Mumbai-400086, Maharashtra, India

Tel. No.:

91-22-61471919 / 25003747 / 25000970 / 25000278

Fax No.:

91-22-40951920 / 25005764 / 25002468

 

 

 

 

Factory 1 :

Plot No. W-239(B), MIDC Industrial Area, Phase II, Dombivali (East), Thane, Maharashtra, India

 

 

Factory 2 :

Plot No. B-6 in Dindori Industrial Area, Village Palkhed, Taluka Dindori, District Nasik, Maharashtra, India

 

 

DIRECTORS

 

AS ON 30.09.2011

 

Name :

Dr. Gangandhar Warke

Designation :

Managing Director

Address :

A-15, Megh Malhar, Gawand Path, Naupada, Thane – 400 602, Maharashtra, India

Date of Birth/Age :

16.09.1941

Date of Appointment :

08.09.1992

PAN No.:

AAAPW0772D

DIN No.:

00131921

 

 

Name :

Mr. Vishnu Warke

Designation :

Whole Time Director

Address :

C-2/ 1002, 10th Floor, Lok Everest, J. D. Road, Mulund, Mumbai – 400 080, Maharashtra, India

Date of Birth/Age :

03.07.1945

Date of Appointment :

08.09.1992

PAN No.:

AAAPW2012N

DIN No.:

00143047

 

 

Name :

Mr. Vishal Gangadhar Warke

Designation :

Whole Time Director

Address :

131, 13th Floor, Prime Rose Gladys A Lverex Road-Village Majiwade, Thane – 400 607, Maharashtra, India

Date of Birth/Age :

29.04.1973

Date of Appointment :

01.08.2004

PAN No.:

AAIPW9404G

DIN No.:

00143167

 

 

Name :

Mr. Anil Tryambak Warke

Designation :

Whole Time Director

Address :

Mathura Anandghan Co-Operative Society, Sant Namdeo Path, Dombivali (East), Thane – 421 201, Maharashtra, India

Date of Birth/Age :

30.07.1960

Date of Appointment :

01.05.1998

PAN No.:

AAAPW2003R

DIN No.:

00143275

 

 

Name :

Mr. Rahul Gangadhar Warke

Designation :

Whole Time Director

Address :

134, 13th Floor, Prime Rose Gladys Al Wares Marg, Pokhran Road No.2, Thane – 400 602, Maharashtra, India

Date of Birth/Age :

19.09.1974

Date of Appointment :

01.04.2006

PAN No.:

AAIPW9403B

DIN No.:

00143397

 

 

Name :

Mrs. Priti Vishal Warke

Designation :

Whole Time Director

Address :

A-15, Megh Malhar, Gawand Path, Naupada, Thane – 400 602, Maharashtra, India

Date of Birth/Age :

11.12.1976

Date of Appointment :

01.08.2005

PAN No.:

AAQPW2037H

DIN No.:

00809839

 

 

Name :

Mr. Rajas Vishnu Warke

Designation :

Director

Address :

A/ 9, Trupti Apartments, Mulund (East), Mumbai – 400 081, Maharashtra, India

Date of Birth/Age :

06.02.1978

Date of Appointment :

16.06.2008

PAN No.:

AAIPW9405H

DIN No.:

02247355

 

 

Name :

Mr. Pravin Tryambak Warke

Designation :

Whole Time Director

Address :

Madhura Building, Anandgaon Sant Namdeo Path, Dombivli, Thane – 421 201, Maharashtra, India

Date of Birth/Age :

15.07.1965

Date of Appointment :

01.08.2005

PAN No.:

AAAPW2137Q

DIN No.:

01672973

 

 

KEY EXECUTIVES

 

Name :

Mr. Basant

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2011

 

Names of Shareholders

No. of Shares

Gangadhar M. Warke

60201

Vishnu M. Warke

60201

Tryambak M. Warke

680

Jyoti A. Warke

Anil T. Warke

1350

Pravin. T. Warke

T. M. Warke

180

Pravin T. Warke

Sangeeta. P. Warke

19714

Ramesh T. Warke

T. M Warke

90

R. Ramesh T. Warke

S. R. Warke

19714

Anil T. Warke

T. M. Warke

3960

Anil T. Warke

J. A. Warke

14584

Rajas V. Warke

270

Saroj G. Warke

135

Swati V. Warke

135

Vishal G. Warke

135

Rahul G. Warke

135

Gangadhar M. Warke (HUF)

135

Vishnu M. Warke (HUF)

135

Promino Health Product Private Limited, India

135

Arun Zambre

1

P. T. Warke (HUF), India

90

Sulochana Mahajan

90

R. T. Warke (HUF), India

90

A. T. Warke (HUF), India

90

TOTAL

182250

 

AS ON 30.09.2011

 

Equity Shares Break Up

Percentage of Holding

Directors or relatives of Directors

100.00

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Dehydrated Culture Media, Vegetable Peptones and Microbiological Diagnostic.

 

 

Products :

  • Dehydrated Culture Media 100gm, 500gm and Pouch
  • Animal Tissue Culture Media 1 ltr. and 10 ltr.
  • Plant Tissue Culture Media 1 ltr. and 10 ltr.
  • Bacteriological Differentiation Aids 125ml, 500ml.
  • Antimicrobial Sensitivity Single Discs 50 discs
  • Antimicrobial Sensitivity Octo Discs 10 discs
  • Standardised Chemicals and Ingredients Various

 

 

PRODUCTION STATUS (AS ON : 31.03.2011)

 

Particulars

Unit

Installed Capacity

 

 

 

Biological Dehydrated Culture Media, Media bases

MT

3950 (Approximately)

 

 

GENERAL INFORMATION

 

No. of Employees :

Information not given by the management 

 

 

Bankers :

State Bank of India,

·         Mid Corporate Loan Administration Unit, RTO Lane, Andheri (West), Mumbai – 400 053, Maharashtra, India

·         Commercial Branch, Sion Trombay Road, Chembur, Mumbai-400071, Maharashtra, India

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

Rupee term loans secured

 

 

Rupee term loans banks secured

81.600

14.805

Rupee term loans financial institutions secured

0.000

44.895

Working capital loans secured

 

 

Working capital loans banks secured

251.234

191.277

Loans taken for fixed assets secured

 

 

Loans taken for vehicles secured

0.833

0.769

 

 

 

Total

333.667

251.746

 

NOTES:

 

(A)    State Bank of India Commercial Branch, Chembur (Secured by Equitable Mortgage of factory Building and hypothecation of Certain Machineries.) (Installment falling due within next 12 months Rs. 41.576 Millions ( P.Y – 9.572 Millions) and [Secured by pledge of T. D. Receipts of Bank of face value of Rs.6.000 Millions ( P.Y. : Rs. 6.000 Millions) ]

 

(B)    State Bank of India Commercial Branch Chembur (Secured by Equitable Mortgage of factory Building and hypothecation of Certain Machineries.) (Installment falling due within next 12 months Rs. 9.572 Millions) and [Secured by pledge of T. D. Receipts of Bank of face value of Rs.6.000 Millions ( P.Y. : Rs.6.984 Millions) ]

 

(C)    Against assignment of Kayman life Insurance policies Installment falling due within next 12 months Rs. Nil (P.Y. Rs. 44.895 Millions)

 

(D)    The Facilities from State Bank of India are additionally secured by collateral security by way of hypothecation of all moveable machineries, equitable mortgage of factory premises, certain office premises and also by personal guarantees of four of the Directors

 

(E)    The Facilities from State Bank of India are additionally secured by collateral security by way of hypothecation of all moveable machineries, equitable mortgage of factory premises, certain office premises and also by personal guarantees of four of the Directors

 

 

(F)    Other Scheduled Bank and Financial Institution (Secured by hypothecation of Motor Car and personal guarantee of all Directors) [Installments falling due within 12 months from the date of Balance Sheet Rs. 0.425 Million (P.Y. Rs. 0.640 Million)]

 

(G)   Other Scheduled Bank and Financial Institution (Secured by hypothecation of Motor Car and personal guarantee of all Directors) [Installments falling due within 12 months from the date of Balance Sheet Rs.0.640 Million (P.Y. Rs. 0.965 Million)]

 

 

Unsecured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

Loans directors unsecured

94.145

51.044

Deposits related parties unsecured

34.851

23.041

Deferred sales tax loan unsecured

119.927

103.033

 

 

 

Total

248.923

177.118

 

NOTES:

 

(A)    Sales Tax Collection under Deferral Scheme of Government of Maharashtra to be remitted after 12 years from first year of payable /disbursal (Installments falling due within next 12 months C.Y.: Rs. NIL P.Y.: Rs. NIL)

 

(B)    Sales Tax Collection under Deferral Scheme of Government of Maharashtra to be remitted after 12 years from first year of payable / disbursal ( Installments falling due within next 12 months C.Y.: Rs. NIL P.Y.: Rs. NIL)

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

A.B. Jog and Company

Chartered Accountants

Address :

604-B, Manisha Apartments, Church Road, Marol, Andheri (East), Mumbai - 400 059, Maharashtra, India

Tel. No.:

91-22-28209245

Fax No.:

91-22-24313042

PAN No.:

AAFPJ0523Q

 

 

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

Warkem Biotech Private limited

CIN No.:- U24200MH2005PTC150416

 

Pure Nutriplant Chemicals Private limited

CIN No.:-  U24110MH1982PTC026881

 

Promino Health Products Private limited

CIN No.:-  U24116MH1984PTC034825

 

·         Agencia La Diagnos

·         X-pert Computer Consultants

·         Biopharmaceutical Enterprises

·         H.P. Works

·         Biotech Consultants

·         Promino Products

·         Warke Family Trust

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2011

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

200000

Equity Shares

Rs.100/- each

Rs. 20.000 Millions

 

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

182250

Equity Shares

Rs.100/- each

Rs. 18.225 Millions

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

18.225

18.225

18.225

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

494.432

375.610

307.924

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

512.657

393.835

326.149

LOAN FUNDS

 

 

 

1] Secured Loans

333.667

251.746

248.712

2] Unsecured Loans

248.923

177.118

159.678

TOTAL BORROWING

582.590

428.864

408.390

DEFERRED TAX LIABILITIES

13.741

11.568

11.578

 

 

 

 

TOTAL

1108.988

834.267

746.117

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

387.414

274.843

258.068

Capital work-in-progress

44.461

61.071

18.844

Expenditure Pending Allotment

0.373

0.247

0.000

 

 

 

 

INVESTMENT

0.003

0.002

0.003

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

469.513
374.316
303.398

 

Sundry Debtors

290.433
245.344
219.830

 

Cash & Bank Balances

177.337
99.431
95.018

 

Other Current Assets

31.413
20.590
23.075

 

Loans & Advances

224.057
202.441
51.033

Total Current Assets

1192.753

942.122

692.354

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

168.296
160.422

104.932

 

Other Current Liabilities

148.382
106.767

83.717

 

Provisions

199.424
176.937
34.632

Total Current Liabilities

516.102

444.126

223.281

Net Current Assets

676.651
497.996

469.073

 

 

 

 

MISCELLANEOUS EXPENSES

0.086

0.108

0.129

 

 

 

 

TOTAL

1108.988

834.267

746.117

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

1456.996

1233.508

1140.121

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

NA

NA

NA

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PROFIT BEFORE TAX

229.673

152.448

149.218

 

 

 

 

 

Less

TAX                                                                 

67.570

43.523

46.045

 

 

 

 

 

 

PROFIT AFTER TAX

162.103

108.925

103.173

 

 

 

 

 

Add

Prior Period Adjustments and Written back/ off

(0.777)

0.335

0.884

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

16.596

15.295

15.063

 

 

 

 

 

 

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

108.335

66.385

61.180

 

 

Dividend (Interim and Final)

36.450

36.450

36.450

 

 

Tax on Dividend

6.054

6.195

6.195

 

BALANCE CARRIED TO THE B/S

27.083

16.596

15.295

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

395.527

392.891

402.267

 

TOTAL EARNINGS

395.527

392.891

402.267

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

253.465

169.618

161.723

 

 

Capital Goods

12.241

9.196

6.958

 

TOTAL IMPORTS

265.706

178.814

168.681

 

 

 

 

 

 

Earnings Per Share (Rs.)

884.65

599.51

570.95

 

 


KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

Net Profit Margin

(PBT/Sales)

(%)

15.76

12.36

13.09

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

14.53

12.53

15.70

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.45

0.39

0.46

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.17

2.25

1.94

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.31

2.12

3.10

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter’s background

Yes

8]

No. Of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----

26]

Buyer visit details

----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

PAN of Proprietor/Partner/Director, if available

Yes

32]

Passport No of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

 

 

SUNDRY CREDITORS DETAILS

(Rs. In Millions)

Particulars

 

31.03.2011

31.03.2010

31.03.2009

Sundry Creditors

 

 

 

Creditors due small micro enterprises

7.900

18.943

57.260

Creditors due others

160.396

141.479

47.672

TOTAL

168.296

160.422

104.932

 

 

OPERATIONS

 

The company registered an increase in domestic turnover by 27 % while export it is only marginal by 5% over that of the previous year. This is the result of the marketing efforts of the directors.

 

As expected and mentioned in their report last year, they had targeted a turnover of Rs.1480.000 Millions. The management was successful in achieving the target inspite of recessionary conditions throughout the world. The turnover would have been higher if the Company had not faced problems such as the non availability of timely raw materials, delays in getting domestic orders and delay in getting overseas contracts which were expected to contribute to the turnover of the company. These have since been finalized.

 

The sales promotion efforts are continuously going on and enabling the company to exploit the full potential of markets in India and abroad. This is evident from the increased turnover for the year in spite of competitive conditions in the country and the global economy. A better utilization of resources has enabled the continuation of growth trend in profit after tax for the year. The healthcare scenario of the country has been changing for the better due to increased awareness from the government and among the general public. An encouraging quantum of enquiries is being received. The turnover for the first five months of the current year, which is normally a lean period, has amounted to Rs.550.800 Millions. The directors are optimistically confident of not only achieving a target of Rs.1750.000 Millions set for the current year, but exceeding the same.

 

During the year, the company has taken strides in the introduction of new products. These products are the results of the Research and Development efforts of the company in the field of vegetable based peptone, Plant tissue culture cells, and monoclonal and polyclonal antibodies, Animal cell culture media and Mol Bio kits. These products are finding acceptability in domestic and foreign existing and new markets. Kits to test rapid growth of bacteria are being well accepted. Various in-vitro diagnostic reagents continue to find a ready global market. Company introduced during the year complete detection of Sickle cell kit in Hematology range, harmonized media for Pharmaceutical industries and developed economical version of water testing kit.

 

The company has already started successfully marketing Hiveg products in USA. Also regular media are also created beside veg products. Also company is targeting Hiveg products in fermentation industries where animal based products will be replaced.

 

With these circumstances your directors are hopeful of achieving the projected turnover in this financial year also.

 

PALKHED -DINDORI –NEW PROJECT

 

The Directors foresee very bright future for their products and received offers from various foreign established brands to get manufactured their products at the Company’s facilities. Many industries from India and abroad are interested to use in their liquid cell culture media of plant and animal instead of creating at their premises. Considering all these new avenue, the Directors have already purchased new industrial plot adjacent to present factory for future expansion and to fulfill future demand of their products. The Construction of the factory has been completed in March’2011. The new premises will be used for standardized chemicals, soil testing

 

The directors are confident that the plant will significantly contribute to the turnover and profitability of the company. The Plant has been designed and built to comply with latest G.M.P. norms laid down for related Pharmaceutical Sector.

 

 

FORM 8

 

Corporate identity number of the company

U85195MH1982PTC028194

Name of the company

HIMEDIA LABORATORIES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

23, Vadhani Industrial Estate, L.B.S. Marg, Ghatkopar (West), Mumbai – 400 086, Maharashtra, India

This form is for

Modification of charge

Charge identification number of the charge to be modified

90242142

Type of charge

·         Immovable property

Particular of charge holder

State Bank of India, Commercial Branch, Sion Trombay Road, Chembur, Mumbai-400071, Maharashtra, India

Nature of instrument creating charge

Memorandum of Deposit for Creation of Further Charge

Date of instrument Creating the charge

03.01.2012

Amount secured by the charge

Rs. 429.700 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Extent and operation of the charge – First charge

Short particulars of the property charged (Including location of the property)

Land bearing Plot No. B-6 in Dindori Industrial Area, Village Palkhed, Taluka Dindori, District Nasik, Maharashtra, admn. 11,013 sq. meters.

 

Land bearing Plot No. B-6 in Dombivli Industrial Area, Phase II, Village Sagaon, District Thane, Maharashtra, admn. 2,701.50 sq. meters together with structures standing thereon admn. 471.21 sq. meters.

 

Land bearing Plot No. B-4 and B-5  in Dindori Industrial Area, Village Palkhed, Taluka Dindori, District Nasik, Maharashtra, admn. 25151 sq. meters along with Factory Building Constructed thereon.

 

Land bearing Plot No.W-239B in Dombivli Industrial Area, Phase II, Village Sagaon, District Thane, Maharashtra, admn. 800.00 sq. meters along with Factory Building Constructed thereon

 

Gala No17, admn. 725 sq. ft., Situated on 1st Floor of Vadhani Industrial Estate, LBS Marg, Ghatkopar (West), Mumbai-400086

 

Gala No. 22, admn. 900 sq. ft., Situated on 1st Floor of Vadhani Industrial Estate, LBS Marg, Ghatkopar (West), Mumbai-400086

 

Gala No. 23, admn.893 sq. ft., Situated on 1st Floor of Vadhani Industrial Estate, LBS Marg, Ghatkopar (West), Mumbai-400086

Date of instrument modifying the charge

21.04.2011

Particulars of the present modification

Equitable mortgage created on 30.04.2003 on immovable properties of the Company as described in Column 15 above and extended from time to time to further secure the enhanced/revised credit facilities, again extended to further secure the enhanced credit facilities of Rs. 429.700 Millions.

 

 

FIXED ASSETS

 

·         Land

·         Factory Building

·         Machinery

·         Books

·         Furniture

·         Electrical Fittings

·         Computer

·         Moulds and Dies

·         Office Equipment

·         Business Equipment

·         Air Conditioner

·         Vehicles

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 56.01

UK Pound

1

Rs. 86.89

Euro

1

Rs. 67.83

 

 

INFORMATION DETAILS

 

Information Gathered by :

PJA

 

 

Report Prepared by :

DPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

53

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.